Abbott reports second-quarter 2024 results and raises full-year guidance

Sales of $10.4 billion driven by strong underlying base business performance reported sales growth of 4.0 percent; organic sales growth for underlying base business of 9.3 percent1, led by double-digit growth in medical devices continues to strengthen portfolio with new product approvals abbott park, ill., july 18, 2024 /prnewswire/ -- abbott (nyse: abt) today announced financial results for the second quarter ended june 30, 2024.
ABT Ratings Summary
ABT Quant Ranking